SynthesisJournal for immunotherapy of cancer2024

Treatment-emergent antidrug antibodies related to PD-1, PD-L1, or CTLA-4 inhibitors across tumor types: a systematic review.

Peter Galle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.